PARP Inhibition Synergizes with Melphalan but Does not Reverse Resistance Completely

Patel, PR; Senyuk, V; Sweiss, K; Calip, GS; Pan, D; Rodriguez, N; Oh, A; Mahmud, N; Rondelli, D

Patel, PR (corresponding author), Univ Illinois, Div Hematol Oncol, 840 S Wood St,820-E, Chicago, IL 60612 USA.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (7): 1273

Abstract

YHigh-dose melphalan (MEL) and autologous stem cell transplantation (ASCT) is the standard of care in the treatment of multiple myeloma (MM). Resistan......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索